Mr James Cochrane
Chair

Chairman, NHS Innovations London

Until the recent merger of the London Strategic Health Authorities, James was Chair of the Board of the South West London Strategic Health Authority. Before joining the SHA, he was a Director and member of the Executive Committee at GlaxoWellcome plc from 1995 until retirement in 2001, with responsibility for European operations. From 1971 to 1990, he held various positions at Bristol Myers-Squibb (and its predecessor companies), becoming President, Northern Europe in 1989. James is also Chairman of TNT n.v., and is on the boards of the London School of Tropical Medicine as well as Medicines for Malaria Venture. He has been appointed recently as Chairman designate for the Britsh Red Cross.